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Background
The aim is to present the results of the two-years’ experi-
ence in the anesthetic management for percutaneous
transcatheter aortic valve implantation (TAVI) procedures.
Methods
All procedures were performed in period between
March 2011 and May 2013.In that period, 26 procedures
performed in patients with severe aortic stenosis: of
total, sixteen patents received Medtronic/CORE valve.
Ten patients received Edwards/Sapien Aortic Bioprosth-
esis, of which, one implanted by transaortic way. The
average age was 78.43 years. In premedication, all
received midazolam 5 mg and clopidogrel 150 mg. All
procedures were performed in general anesthesia using
sevoflurane, small doses of i.v. fentanyl and rocuronium at
the start of the procedure. Anesthesia maintained with
sevoflurane up to the end of procedure. Rapid ventricular
pacing achieved with transvenous temporary pacemaker.
For evaluation of aortic valve, aortic root, left ventricular
outflow tract pre and after procedure, in all patients trans-
esophageal echocardiography (TEE) was used.
Results
The valve was successfully implanted in 25 patients; one
valve could not be positioned adequately. In seven
patients, TEE evaluation showed needing for valve re-
expanding due to perivalvular leak. Four patients needed
short usage of norepinephrine due to hemodynamic
instability. 21 patients were extubated in hybrid operating
room and transferred to ICU for the next 24 hours. Early
postoperative complications included new left bundle
branch block in one patient, one stroke and one heart
failure in further two patients. All patients discharged
from hospital within 7 to 10 days after the procedure in
good conditions.
Conclusion
TAVI procedure has successful outcome in selected
high-risk patients. General anesthesia is optional because
it provides better hemodynamic stability, it is more
comfortable for the patient, and finally, facilitates better
conditions for precise and extremely important TEE
estimations during procedure.
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